SNDL Inc. (SNDL) stock
SNDLNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$1.34+0.00 (0.00%)
Close on Nov 17, 2026Market cap $352.90MP/E –Yield –
SNDL r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2026 it was C$489.00K, up 41.3% from the year before. The highest annual figure on record is C$2.45M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Dec 31, 2025 | C$489.00K | +41.3% |
| FY2025 | Dec 31, 2024 | C$346.00K | +6.8% |
| FY2024 | Dec 31, 2023 | C$324.00K | -86.8% |
| FY2023 | Dec 31, 2022 | C$2.45M | +0.1% |
| FY2022 | Dec 31, 2021 | C$2.45M | +401.2% |
| FY2021 | Dec 31, 2020 | C$488.00K | -79.8% |
| FY2020 | Dec 31, 2019 | C$2.41M | +483.5% |
| FY2018 | Feb 28, 2018 | C$413.00K | – |
See a number that looks wrong?